ANTI-SORTILIN ANTIBODIES AND METHODS OF USE THEREOF

    公开(公告)号:US20190085084A1

    公开(公告)日:2019-03-21

    申请号:US16134830

    申请日:2018-09-18

    Applicant: Alector LLC

    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a Sortilin protein, e.g., human Sortilin or a mammalian Sortilin, and use of such compostions in preventing, reducing risk, or treating an individual in need thereof.

    ANTI-SORTILIN ANTIBODIES AND METHODS OF USE THEREOF

    公开(公告)号:US20190062433A1

    公开(公告)日:2019-02-28

    申请号:US16058817

    申请日:2018-08-08

    Applicant: ALECTOR LLC

    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a Sortilin protein, e.g., human Sortilin or a mammalian Sortilin, and use of such compostions in preventing, reducing risk, or treating an individual in need thereof.

    Anti-sortilin antibodies and methods of use thereof

    公开(公告)号:US10087255B2

    公开(公告)日:2018-10-02

    申请号:US15285359

    申请日:2016-10-04

    Applicant: ALECTOR LLC

    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a Sortilin protein, e.g., human Sortilin or a mammalian Sortilin, and use of such compostions in preventing, reducing risk, or treating an individual in need thereof.

Patent Agency Ranking